111 Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$738K Buy
+4,916
New +$535K 0.13% 165
2025
Q1
Sell
-8,303
Closed -$254K 512
2024
Q4
$254K Buy
+8,303
New +$234K 0.05% 324

Other funds holding GH

111 Capital's GH Position: Q2 2026 in Review

111 Capital opened a new position in Guardant Health (GH) in Q2 2026: 4,916 shares worth $738K. The stake represents 0.13% of the portfolio and ranks #165 among its holdings. This is a return to the name: 111 Capital previously reported a position in GH as recently as Q4 2024.

111 Capital first reported a position in GH in Q4 2024 and has held it in 2 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • 111 Capital held 4,916 shares of Guardant Health worth $738K as of Q2 2026.
  • Guardant Health was a new 111 Capital position in Q2 2026.
  • Guardant Health made up 0.13% of 111 Capital's portfolio in Q2 2026, its #165 holding.
  • 111 Capital first reported a position in Guardant Health in Q4 2024 and has held it in 2 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.